ANNOUNCEMENTS
This thesis explores the intersection of intellectual property rights and microbial biotechnology, focusing on the formulation of a robust framework for patent drafting and commercialization. With increasing global emphasis on environmental sustainability, microbial technologies such as bioremediation, microplastic degradation, and carbon sequestration have emerged as critical innovations. However, their successful deployment relies heavily on clear, enforceable, and commercially viable patent protection.
The research was undertaken through a practice-oriented internship at IP Quad Partners, where practical exposure to drafting claims, handling official patent forms, and analysing prior art using tools like Google Patents, Espacenet, WIPO PATENTSCOPE, and The Lens was gained. Real-world case studies, including microbial inventions and AI-integrated technologies, were examined to understand novelty, inventive step, and commercial potential. The thesis also reviews relevant international treaties (PCT, TRIPS, Paris Convention) and the Indian Patents Act, highlighting jurisdictional nuances and procedural frameworks.
A seven-step strategic model is proposed, encompassing invention disclosure, prior art search, drafting, visual documentation, filing procedures, market-fit assessment, and commercialization outreach. Key challenges such as ambiguity in biotech claims, legal risks, and biodiversity compliance are addressed through doctrinal insights and landmark case laws like Novartis v. Union of India, Diamond v. Chakrabarty, and Myriad Genetics.
By integrating technical, legal, and business dimensions, this thesis offers a comprehensive guide to transforming innovative microbial solutions into IPprotected, market-ready assets that can contribute meaningfully to environmental goals.
